大阪大学のジスルフィド結合研究、Byosによるバイオ医薬品のPTM解析、AAV脱アミド化研究による不均一性の解明をご紹介します。

Every protein leaves a footprint. Read it — automatically — to map binding partners and their interaction interfaces in a single experiment.

Why a single fragmentation mode leaves gaps, and how a hybrid strategy closes them for confident, end-to-end characterization.

Rituxan and three FDA-approved biosimilars. Same sequence, very different insides — and the microheterogeneity tracks with ADCC potency.

Advancing LC-UV-MS workflows with Byos for high-throughput oligonucleotide characterization in early drug discovery

What's hiding inside? A new multi-protein workflow uncovers the unexpected in HCP analysis

Lysine-conjugated ADCs are complex — GingisREX® digestion + Byos workflows deliver clearer peptide quantification and deeper conjugation insights.

How Genentech combined liquid handling automation with Byos software to save 2-3 days per week across disulfide, PTM, and glycation workflows

Spot the winner in a crowded sky: Automated native MS for rapid hit discovery

Blueprints to Results: Mapping IgG2 Structural Complexity

From Low to Flow: A Mass Spec-tacular Leap in Throughput

Speed TCR structural mapping using cross-linking MS and Byosphere to streamline analysis and boost drug design decisions.